RICHARD F POPS Insider Trading $NBIX NEUROCRINE BIOSCIENCES INC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for RICHARD F POPS.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of RICHARD F POPS. RICHARD F POPS is Chief Executive Officer in ALKERMES INC ($ALKS) and Director in ALKERMES INC ($ALKS) and President and CEO in ALKERMES INC ($ALKS) and Director in NEUROCRINE BIOSCIENCES INC ($NBIX) and Director in ACCELERON PHARMA INC ($XLRN) and Director and CEO, Alkermes plc in Alkermes plc. ($ALKS) and Director in Epizyme, Inc. ($EPZM).
RICHARD F POPS in NEUROCRINE BIOSCIENCES INC
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of RICHARD F POPS: Director
Holdings: 29,512 shares
Current Value: $1,286,723
Latest Transaction: May 20 2021
$NBIX Market Capitalization: $3.81B
$NBIX Previous Close: $43.60
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of RICHARD F POPS in NEUROCRINE BIOSCIENCES INC
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, XLRN, ALKS, ALKS, EPZM, NBIX
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 20 2021 | NBIX | NEUROCRINE BIOSCIE ... | POPS RICHARD F | Director | Option Exercise | A | 92.35 | 8,833 | 815,728 | 8,833 | |
| May 21 2020 | NBIX | NEUROCRINE BIOSCIE ... | POPS RICHARD F | Director | Option Exercise | A | 119.93 | 6,018 | 721,739 | 6,018 | |
| May 23 2019 | NBIX | NEUROCRINE BIOSCIE ... | POPS RICHARD F | Director | Option Exercise | A | 79.79 | 10,000 | 797,900 | 10,000 | |
| Nov 27 2018 | NBIX | NEUROCRINE BIOSCIE ... | POPS RICHARD F | Director | Sell | S | 91.37 | 4,124 | 376,790 | 29,512 | 33.6 K to 29.5 K (-12.26 %) |
| Nov 13 2018 | NBIX | NEUROCRINE BIOSCIE ... | POPS RICHARD F | Director | Sell | S | 103.30 | 4,123 | 425,893 | 33,636 | 37.8 K to 33.6 K (-10.92 %) |
| Oct 30 2018 | NBIX | NEUROCRINE BIOSCIE ... | POPS RICHARD F | Director | Sell | S | 107.13 | 5,500 | 589,237 | 37,759 | 43.3 K to 37.8 K (-12.71 %) |
| May 25 2018 | NBIX | NEUROCRINE BIOSCIE ... | POPS RICHARD F | Director | Option Exercise | A | 94.64 | 12,500 | 1,183,000 | 12,500 | |
| May 25 2018 | NBIX | NEUROCRINE BIOSCIE ... | POPS RICHARD F | Director | Option Exercise | A | 94.64 | 12,500 | 1,183,000 | 12,500 | |
| May 03 2018 | NBIX | NEUROCRINE BIOSCIE ... | POPS RICHARD F | Director | Option Exercise | M | 7.05 | 15,000 | 105,750 | 0 | |
| May 03 2018 | NBIX | NEUROCRINE BIOSCIE ... | POPS RICHARD F | Director | Payment of Exercise | F | 84.39 | 1,253 | 105,741 | 43,259 | 44.5 K to 43.3 K (-2.81 %) |
| May 03 2018 | NBIX | NEUROCRINE BIOSCIE ... | POPS RICHARD F | Director | Buy | M | 7.05 | 15,000 | 105,750 | 44,512 | 29.5 K to 44.5 K (+50.83 %) |
| Jun 08 2017 | NBIX | NEUROCRINE BIOSCIE ... | POPS RICHARD F | Director | Option Exercise | A | 53.64 | 15,000 | 804,600 | 15,000 | |
| May 05 2017 | NBIX | NEUROCRINE BIOSCIE ... | POPS RICHARD F | Director | Option Exercise | M | 3.40 | 15,000 | 51,000 | 0 | |
| May 05 2017 | NBIX | NEUROCRINE BIOSCIE ... | POPS RICHARD F | Director | Payment of Exercise | F | 53.37 | 952 | 50,808 | 29,512 | 30.5 K to 29.5 K (-3.12 %) |
| May 05 2017 | NBIX | NEUROCRINE BIOSCIE ... | POPS RICHARD F | Director | Buy | M | 3.40 | 15,000 | 51,000 | 30,454 | 15.5 K to 30.5 K (+97.06 %) |
| May 26 2016 | NBIX | NEUROCRINE BIOSCIE ... | POPS RICHARD F | Director | Sell | S | 46.72 | 15,000 | 700,800 | 15,464 | 30.5 K to 15.5 K (-49.24 %) |
| May 24 2016 | NBIX | NEUROCRINE BIOSCIE ... | POPS RICHARD F | Director | Option Exercise | A | 47.89 | 15,000 | 718,350 | 15,000 | |
| May 18 2016 | NBIX | NEUROCRINE BIOSCIE ... | POPS RICHARD F | Director | Option Exercise | M | 3.07 | 15,000 | 46,050 | 0 | |
| May 18 2016 | NBIX | NEUROCRINE BIOSCIE ... | POPS RICHARD F | Director | Payment of Exercise | F | 45.64 | 1,008 | 46,005 | 30,464 | 31.5 K to 30.5 K (-3.20 %) |
| May 18 2016 | NBIX | NEUROCRINE BIOSCIE ... | POPS RICHARD F | Director | Buy | M | 3.07 | 15,000 | 46,050 | 31,472 | 16.5 K to 31.5 K (+91.06 %) |
| Jun 01 2015 | NBIX | NEUROCRINE BIOSCIE ... | POPS RICHARD F | Director | Option Exercise | A | 42.76 | 25,000 | 1,069,000 | 25,000 | |
| May 13 2015 | NBIX | NEUROCRINE BIOSCIE ... | POPS RICHARD F | Director | Option Exercise | M | 4.76 | 15,000 | 71,400 | 0 | |
| May 13 2015 | NBIX | NEUROCRINE BIOSCIE ... | POPS RICHARD F | Director | Payment of Exercise | F | 39.63 | 1,801 | 71,374 | 16,472 | 18.3 K to 16.5 K (-9.86 %) |
| May 13 2015 | NBIX | NEUROCRINE BIOSCIE ... | POPS RICHARD F | Director | Buy | M | 4.76 | 15,000 | 71,400 | 18,273 | 3.3 K to 18.3 K (+458.30 %) |
Page: 1